位置:首页 > 蛋白库 > TOR_CAEEL
TOR_CAEEL
ID   TOR_CAEEL               Reviewed;        2697 AA.
AC   Q95Q95; O01438;
DT   16-JAN-2004, integrated into UniProtKB/Swiss-Prot.
DT   16-JAN-2004, sequence version 3.
DT   03-AUG-2022, entry version 159.
DE   RecName: Full=Target of rapamycin homolog;
DE            EC=2.7.11.1;
DE   AltName: Full=CeTOR;
DE   AltName: Full=Lethal protein 363;
GN   Name=let-363 {ECO:0000312|WormBase:B0261.2a};
GN   Synonyms=CeTor {ECO:0000312|WormBase:B0261.2a};
GN   ORFNames=B0261.2 {ECO:0000312|WormBase:B0261.2a};
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditina; Rhabditomorpha; Rhabditoidea; Rhabditidae; Peloderinae;
OC   Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM A), FUNCTION, SUBCELLULAR
RP   LOCATION, AND TISSUE SPECIFICITY.
RC   STRAIN=Bristol N2;
RX   PubMed=12225660; DOI=10.1016/s0960-9822(02)01091-6;
RA   Long X., Spycher C., Han Z.S., Rose A.M., Mueller F., Avruch J.;
RT   "TOR deficiency in C. elegans causes developmental arrest and intestinal
RT   atrophy by inhibition of mRNA translation.";
RL   Curr. Biol. 12:1448-1461(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for investigating
RT   biology.";
RL   Science 282:2012-2018(1998).
RN   [3]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=14668850; DOI=10.1038/426620a;
RA   Vellai T., Takacs-Vellai K., Zhang Y., Kovacs A.L., Orosz L., Mueller F.;
RT   "Genetics: influence of TOR kinase on lifespan in C. elegans.";
RL   Nature 426:620-620(2003).
RN   [4]
RP   TISSUE SPECIFICITY, AND DISRUPTION PHENOTYPE.
RX   PubMed=17327275; DOI=10.1242/jcs.03401;
RA   Toth M.L., Simon P., Kovacs A.L., Vellai T.;
RT   "Influence of autophagy genes on ion-channel-dependent neuronal
RT   degeneration in Caenorhabditis elegans.";
RL   J. Cell Sci. 120:1134-1141(2007).
RN   [5]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=19377305; DOI=10.4161/auto.5.5.8624;
RA   Tian E., Wang F., Han J., Zhang H.;
RT   "epg-1 functions in autophagy-regulated processes and may encode a highly
RT   divergent Atg13 homolog in C. elegans.";
RL   Autophagy 5:608-615(2009).
RN   [6]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=22278922; DOI=10.1242/dev.074047;
RA   Korta D.Z., Tuck S., Hubbard E.J.;
RT   "S6K links cell fate, cell cycle and nutrient response in C. elegans
RT   germline stem/progenitor cells.";
RL   Development 139:859-870(2012).
RN   [7]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=28853436; DOI=10.1038/ncomms16083;
RA   Tiku V., Jain C., Raz Y., Nakamura S., Heestand B., Liu W., Spaeth M.,
RA   Suchiman H.E.D., Mueller R.U., Slagboom P.E., Partridge L., Antebi A.;
RT   "Small nucleoli are a cellular hallmark of longevity.";
RL   Nat. Commun. 8:16083-16083(2016).
CC   -!- FUNCTION: Serine/threonine-protein kinase that regulates the mRNA
CC       translation machinery, probably by modulating the activity of
CC       translation factors such as eIF-4G and eIF-2 (PubMed:12225660). It may
CC       have some protein kinase activity instead of lipid kinase activity
CC       (PubMed:12225660). May play a role in P-granule degradation by
CC       autophagy in somatic cells during embryogenesis (PubMed:19377305).
CC       Required, during larval development, for the establishment of the
CC       proper number of germline progenitors, probably upstream of rsks-1 and
CC       ife-1 (PubMed:22278922). Required for larval development
CC       (PubMed:22278922). May act as a mediator of lifespan regulation by
CC       insulin signaling and nutrient sensing (PubMed:14668850,
CC       PubMed:28853436). {ECO:0000269|PubMed:12225660,
CC       ECO:0000269|PubMed:14668850, ECO:0000269|PubMed:19377305,
CC       ECO:0000269|PubMed:22278922, ECO:0000269|PubMed:28853436}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:12225660}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=a {ECO:0000312|WormBase:B0261.2a};
CC         IsoId=Q95Q95-1; Sequence=Displayed;
CC       Name=b {ECO:0000312|WormBase:B0261.2b};
CC         IsoId=Q95Q95-2; Sequence=VSP_009223;
CC   -!- TISSUE SPECIFICITY: Ubiquitous. Expressed in all major tissues and
CC       organs, including the intestine, gonads and hypodermal cells
CC       (PubMed:12225660). Expressed in neurons (PubMed:17327275).
CC       {ECO:0000269|PubMed:12225660, ECO:0000269|PubMed:17327275}.
CC   -!- DISRUPTION PHENOTYPE: Defects strongly increase lifespan, the mean
CC       lifetime being of 25 days instead of 10 days, suggesting that it may be
CC       involved in aging process (PubMed:14668850). RNAi-mediated knockdown
CC       results in increased longevity and a reduced nucleoli size
CC       (PubMed:28853436). RNAi-mediated knockdown in a ncl-1 mutant background
CC       (e1942) reduces the increased longevity and suppresses the reduced
CC       nucleoli size of the let-363 single mutant, and reduces the increased
CC       ribosomal protein synthesis in the ncl-1 single mutant (e1942)
CC       (PubMed:28853436). RNAi-mediated knockdown in the germline causes
CC       sterility, a severe reduction in the number of germline progenitors and
CC       a delay in G2 phase of the cell cycle (PubMed:22278922). RNAi-mediated
CC       knockdown results in no sepa-1 containing aggregates at the comma stage
CC       of embryonic development indicative of no germ cell specific P-granules
CC       at this stage (PubMed:19377305). RNAi-mediated knockdown enhances the
CC       loss of touch receptor neurons in a mec-4 u231 mutant
CC       (PubMed:17327275). {ECO:0000269|PubMed:14668850,
CC       ECO:0000269|PubMed:17327275, ECO:0000269|PubMed:19377305,
CC       ECO:0000269|PubMed:22278922, ECO:0000269|PubMed:28853436}.
CC   -!- SIMILARITY: Belongs to the PI3/PI4-kinase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BX284601; CCD61569.1; -; Genomic_DNA.
DR   EMBL; BX284601; CCD61570.1; -; Genomic_DNA.
DR   RefSeq; NP_491549.2; NM_059148.4.
DR   RefSeq; NP_491552.2; NM_059151.5.
DR   AlphaFoldDB; Q95Q95; -.
DR   SMR; Q95Q95; -.
DR   BioGRID; 37625; 18.
DR   STRING; 6239.B0261.2a; -.
DR   iPTMnet; Q95Q95; -.
DR   EPD; Q95Q95; -.
DR   PaxDb; Q95Q95; -.
DR   PeptideAtlas; Q95Q95; -.
DR   EnsemblMetazoa; B0261.2a.1; B0261.2a.1; WBGene00002583.
DR   EnsemblMetazoa; B0261.2b.1; B0261.2b.1; WBGene00002583.
DR   GeneID; 172167; -.
DR   KEGG; cel:CELE_B0261.2; -.
DR   UCSC; B0261.2b; c. elegans. [Q95Q95-1]
DR   CTD; 172167; -.
DR   WormBase; B0261.2a; CE32559; WBGene00002583; let-363. [Q95Q95-1]
DR   WormBase; B0261.2b; CE32560; WBGene00002583; let-363. [Q95Q95-2]
DR   eggNOG; KOG0891; Eukaryota.
DR   GeneTree; ENSGT00940000174195; -.
DR   InParanoid; Q95Q95; -.
DR   OrthoDB; 26975at2759; -.
DR   PhylomeDB; Q95Q95; -.
DR   Reactome; R-CEL-1257604; PIP3 activates AKT signaling.
DR   Reactome; R-CEL-1632852; Macroautophagy.
DR   Reactome; R-CEL-165159; MTOR signalling.
DR   Reactome; R-CEL-166208; mTORC1-mediated signalling.
DR   Reactome; R-CEL-3371571; HSF1-dependent transactivation.
DR   Reactome; R-CEL-380972; Energy dependent regulation of mTOR by LKB1-AMPK.
DR   Reactome; R-CEL-389357; CD28 dependent PI3K/Akt signaling.
DR   Reactome; R-CEL-5218920; VEGFR2 mediated vascular permeability.
DR   Reactome; R-CEL-5628897; TP53 Regulates Metabolic Genes.
DR   Reactome; R-CEL-6804757; Regulation of TP53 Degradation.
DR   Reactome; R-CEL-8943724; Regulation of PTEN gene transcription.
DR   Reactome; R-CEL-9639288; Amino acids regulate mTORC1.
DR   PRO; PR:Q95Q95; -.
DR   Proteomes; UP000001940; Chromosome I.
DR   Bgee; WBGene00002583; Expressed in germ line (C elegans) and 4 other tissues.
DR   GO; GO:0005737; C:cytoplasm; IDA:WormBase.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0031931; C:TORC1 complex; IDA:WormBase.
DR   GO; GO:0031932; C:TORC2 complex; IDA:WormBase.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004672; F:protein kinase activity; ISS:WormBase.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IBA:GO_Central.
DR   GO; GO:0044877; F:protein-containing complex binding; IEA:InterPro.
DR   GO; GO:0000492; P:box C/D snoRNP assembly; IMP:WormBase.
DR   GO; GO:0008340; P:determination of adult lifespan; IMP:UniProtKB.
DR   GO; GO:0048382; P:mesendoderm development; IGI:WormBase.
DR   GO; GO:0010629; P:negative regulation of gene expression; IMP:UniProtKB.
DR   GO; GO:0016242; P:negative regulation of macroautophagy; IBA:GO_Central.
DR   GO; GO:0002119; P:nematode larval development; IMP:WormBase.
DR   GO; GO:0010628; P:positive regulation of gene expression; IMP:UniProtKB.
DR   GO; GO:0045727; P:positive regulation of translation; IMP:WormBase.
DR   GO; GO:0006468; P:protein phosphorylation; ISS:WormBase.
DR   GO; GO:0006417; P:regulation of translation; IMP:WormBase.
DR   GO; GO:1903935; P:response to sodium arsenite; IGI:UniProtKB.
DR   GO; GO:0031929; P:TOR signaling; IMP:WormBase.
DR   Gene3D; 1.10.1070.11; -; 1.
DR   Gene3D; 1.20.120.150; -; 1.
DR   Gene3D; 1.25.10.10; -; 3.
DR   InterPro; IPR011989; ARM-like.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR024585; DUF3385_TOR.
DR   InterPro; IPR003152; FATC_dom.
DR   InterPro; IPR009076; FRB_dom.
DR   InterPro; IPR036738; FRB_sf.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000403; PI3/4_kinase_cat_dom.
DR   InterPro; IPR036940; PI3/4_kinase_cat_sf.
DR   InterPro; IPR018936; PI3/4_kinase_CS.
DR   InterPro; IPR003151; PIK-rel_kinase_FAT.
DR   InterPro; IPR014009; PIK_FAT.
DR   InterPro; IPR026683; TOR.
DR   PANTHER; PTHR11139:SF9; PTHR11139:SF9; 1.
DR   Pfam; PF11865; DUF3385; 1.
DR   Pfam; PF02259; FAT; 1.
DR   Pfam; PF02260; FATC; 1.
DR   Pfam; PF08771; FRB_dom; 1.
DR   Pfam; PF00454; PI3_PI4_kinase; 1.
DR   SMART; SM01346; DUF3385; 1.
DR   SMART; SM01343; FATC; 1.
DR   SMART; SM00146; PI3Kc; 1.
DR   SUPFAM; SSF47212; SSF47212; 1.
DR   SUPFAM; SSF48371; SSF48371; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS51189; FAT; 1.
DR   PROSITE; PS51190; FATC; 1.
DR   PROSITE; PS00915; PI3_4_KINASE_1; 1.
DR   PROSITE; PS00916; PI3_4_KINASE_2; 1.
DR   PROSITE; PS50290; PI3_4_KINASE_3; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; ATP-binding; Kinase; Nucleotide-binding; Nucleus;
KW   Reference proteome; Repeat; Serine/threonine-protein kinase; Transferase;
KW   Translation regulation.
FT   CHAIN           1..2697
FT                   /note="Target of rapamycin homolog"
FT                   /id="PRO_0000088811"
FT   REPEAT          235..272
FT                   /note="HEAT 1"
FT   REPEAT          649..687
FT                   /note="HEAT 2"
FT   REPEAT          689..726
FT                   /note="HEAT 3"
FT   REPEAT          731..768
FT                   /note="HEAT 4"
FT   REPEAT          815..853
FT                   /note="HEAT 5"
FT   REPEAT          863..900
FT                   /note="HEAT 6"
FT   REPEAT          1073..1110
FT                   /note="HEAT 7"
FT   DOMAIN          1438..2153
FT                   /note="FAT"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00534"
FT   DOMAIN          2332..2647
FT                   /note="PI3K/PI4K catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00269"
FT   DOMAIN          2665..2697
FT                   /note="FATC"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00534,
FT                   ECO:0000255|PROSITE-ProRule:PRU00535"
FT   REGION          1..25
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1945..1981
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          2017..2039
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          2338..2344
FT                   /note="G-loop"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00269"
FT   REGION          2512..2520
FT                   /note="Catalytic loop"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00269"
FT   REGION          2532..2557
FT                   /note="Activation loop"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00269"
FT   REGION          2615..2635
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1965..1979
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   VAR_SEQ         2212..2215
FT                   /note="Missing (in isoform b)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_009223"
FT   CONFLICT        1295
FT                   /note="K -> ISE (in Ref. 2; CCD61569/CCD61570)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1992..1994
FT                   /note="Missing (in Ref. 2; CCD61570)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   2697 AA;  306529 MW;  CBC59D6CE02BFEC0 CRC64;
     MLQQHGISFQ MNADRQNKAA TTSNRIVSAP ATNEFDERHR KQGIDAARAL ASQYRSRITE
     NRDANQRQAA RELSRYVRSE LKDEPNTFSD AFLNAIDGRT DIASQSAIYN CMKSNSNIDQ
     KRAGIYLIVC LAETHSGNVI RYANYLLKML NNGNGLDEDT VKMASKALAF LIATCKSYAA
     ELVDRCLDHC HEWLGQNVPH SQQPKNQQEI DQIRRLAASH LSRELALATP TAFFLRVNLF
     FKYIFNAVRD KNPAVRIAGI DALHVVLTIV SQREAKNKTE WFKKCFDEAL EGQPNPSQKD
     DLDRWHAVAL ILNELLRISD QRFELIRCES SQFIKQKFLK EDEEEGVEWL VLTKQQTIVE
     SVTARKLVLE RFPKILDCVR QIIPLANKTS STKQQSSIYL NTVLMQLLPR ICAFPQCDRT
     FQTISFDTSF TILQRNAVAA PAIGMMMLSN PDVHATHIEK TISFISAAIK KTTNSDVLDN
     YFTFLFLFVD AYHEQVTTQI KAIIPQLMDI TLSRSLANVL KMIMMRIPKL RLNVQDGVMA
     SVYQTLTGSL IPPKSEPIGR PASPKAILQK AETDPKELQR IVLAVDVLGE FYFSRGALQR
     IMQYVADYYL TADNVEIRLA AVSSCCEMVV PFVGVYKKVT SDKRNSLLQT IYGVLRAVCS
     VIVNDQDVRV RMQVISCFGQ MPRPFLAHLA QPEMLEVQFM ALHDEKLEMQ QACVTLLGRL
     AELNPALVLP RLRLMLLETL SQMQQSGQAR LEQHSAKMIA QLAKQSPKFM RPYVGSLMIA
     MIPKLRNDQK YAEVTAQVLN AVSEIAVIGG AEIVKNLKPL FEKLTHMIND SSSLHKREAA
     LRAIGGICRS TAYVVDPYRD YPSLLDDLLR ILKTVMSNTM RREAIKTLGI LGAIDPYTHK
     VFTGSVQSST AISTALSLPI SETDSKDPRQ DIIHWFNYEK CTLEEFYPAI TIANLMLMMQ
     DEDSQSYAEI AQAIVTIFRS LGDMAPLYTE QVIPRLIEVC RRATESSNRA NLREFFLQQL
     ANFVAIIRKH AAPYMPAIFT IIADAWKEDI SVKMVVIEVL TDMGTAIGND FSKYTGELIP
     YLLTVLQTDK TKERVLTVKV MESIQKLTHC IVQHLHLVLP PLLIILDDFS LKLSIRNTAL
     STVLHMTQQV DVSAYAPRMM QSWHHNISTA EMRDKLLLLL IEIIKQLGKF FDIFKRGVDQ
     KLRDYNLDKS VHYEQYRKLA QRAQMSRDVL TSSVFAGSNG NIQYSSTQAG MRGQANNVYA
     NNDLHERLMN GSIDSGASRQ DNRDDYYRYG VEEKKEVPKV APTTARPTSE LVTVQITKQR
     LNKDALMPQW KNENLTSKDE WLQWLMKIRI GFLTYGSSPS LRAASSLGDQ HPHLARDLFP
     AAFMSVWTEL DSDVQNDLTS CLLRAISTGI PELIQTILNL AEFMDHSEKG PLPISHDVLG
     RWAEQTKAFA KACRYKEMSV LKKSGSMQTT FTRKVKLEPN DCQSLITYAN KLNVQEEAAG
     VVRYAERNEM NFQMRGRWYE KLNEWEKALG AYELEEKKKS SCPNLQVYDE KDHLMTPEEA
     ATAEEARMHE MRCLEALGRW DELNSKSVVW ADQRGNRNDS VRDEINKKQL DHKMAVIAAR
     GAWAVDNWER MADYVSVISE NTQDGAMLRA VVAVHNDENT KAMGLIEKVR EMIDSELTAM
     ANESYERAYI PMVSVQQMAE LEEAIEYKTR PERRPRIALL WSRRLQGCRR NVEQWQRLIM
     LRGLVLSPQE MHPLRVKFSS MCRKQGKNSM SRAVLRELLS LPANSDLVRA KAPFDKPLLV
     LALAKQLYQD DHKDEAIRAL EDLANHWNKR INPIPKATGR ELIPPSTKEP ARICAKVLLK
     LGEWTELKSK TSNNMQVGEL SFVRQQVSPQ YRTKESRTPE TIAFENTINY YQQATQYDPG
     WHKVWHKLAS THFYAVCRER PHPTTVISPP QQPQQPKKMH IPPVTRATSP PPPAQKSPQP
     APFHSITEPL SVIIDYPVPP PLGSLVGLPP MPAYLSSNSS LPPQHHHVSP LSNDSPSNSA
     ENKLYLKHAA HAVRCFAKAL MCSPGSRLED TLRLMQLWFD HGDDKDQDVY FALTETIFDL
     PVTTWLEAIP QLMARLDCPD DQKSVQLVLR VLCEIARHRP QAVIYALTVA SRSKDVHRSK
     NAGTVLEKMM EYHSKLVREA SLVTEELVRC AILWHEQWHD ALDDASRVYF HRRLQDNNVQ
     AMFDALRNMN DLMQKGAPTT MKEHSFQQTY SSDLKEAGRY VQAFESSGNV KDLNQAWEIY
     CSVFKKLRDQ LATLNSLDLV YVSPNLVSAK DLELVVPGTY DPSAPIVSIQ SFSSKMNVIT
     SKQRPRKMVI RGSNGLDYQF LLKGHEDPRQ DERVMQLFGL VNTLLANNSE TCRRNLTIQR
     YSIVALSKDS GLIGWVPNCD TLHTLVKEYR EKKAKIPLSI EHKTLQKLSL ETEHLTLMQK
     LQLFESALSV TQGEDLRHVL WLKSPSSEVW FDRRTNYTRS VACMSMVGYI LGLGDRHPSN
     LMLDRLTGKV VHIDFGDCFE VAMLREKFPE RVPFRLTRML INAMEVTGLD GVYNYTAERV
     LKMLRTNQES LLAVLEAFVY DPVINWRLVE GMKKDPKTRK DTGGRQNMAG AVLPSSSTTD
     SIMETIKRKL DGTEFVHTDG STPPEPLQVT EQLAMLTEQA TSPLNLCQSY IGWCPFW
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024